Fig. 1 · Structure
Documents & Downloads
HTL22562
CGRP Receptor Antagonist
HTL22562 is a calcitonin gene-related peptide (CGRP) receptor antagonist that plays a significant role in the study of migraine pathology. It effectively inhibits CGRP receptor activity, which is critical for understanding migraine mechanisms and developing therapeutic strategies. HTL22562 is primarily used in acute research settings to explore the implications of CGRP signaling in headache disorders.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 2097085-63-5 |
| Applications | CGRP Receptor Antagonist |
| Formula | C40H49N11O5 |
| Molecular Weight | 763.89 |
| SMILES | O=C(N1CCC2(OC(NC3=NC=CC=C32)=O)CC1)N[C@H](CC4=CC5=C(NN=C5)C(C)=C4)C(N[C@@H](CC6CCNCC6)C(N7CCN(C8=CC=NC=C8)CC7)=O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.